tiprankstipranks
Trending News
More News >
Vera Therapeutics price target raised to $61 from $59 at Guggenheim
PremiumThe FlyVera Therapeutics price target raised to $61 from $59 at Guggenheim
2M ago
Optimistic Buy Rating for Vera Therapeutics: Strong Financials and Promising Pipeline Drive Positive Outlook
Premium
Ratings
Optimistic Buy Rating for Vera Therapeutics: Strong Financials and Promising Pipeline Drive Positive Outlook
2M ago
Vera Therapeutics selloff a buying opportunity, says Evercore ISI
Premium
The Fly
Vera Therapeutics selloff a buying opportunity, says Evercore ISI
2M ago
3 Best Stocks to Buy Now, 2/18/2025, According to Top Analysts
PremiumMarket News3 Best Stocks to Buy Now, 2/18/2025, According to Top Analysts
2M ago
Buy Rating Affirmed for Vera Therapeutics Amid Promising Atacicept Prospects and Market Overreaction Concerns
Premium
Ratings
Buy Rating Affirmed for Vera Therapeutics Amid Promising Atacicept Prospects and Market Overreaction Concerns
2M ago
Vera reaction to competitor IgAN update ‘overdone,’ says Goldman Sachs
Premium
The Fly
Vera reaction to competitor IgAN update ‘overdone,’ says Goldman Sachs
2M ago
Vera Therapeutics initiated with a Buy at Goldman Sachs
PremiumThe FlyVera Therapeutics initiated with a Buy at Goldman Sachs
3M ago
3 Best Stocks to Buy Now, 1/17/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 1/17/2025, According to Top Analysts
3M ago
Vera Therapeutics Highlights Atacicept Progress at Conference
Premium
Company Announcements
Vera Therapeutics Highlights Atacicept Progress at Conference
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100